BRPI1008008A2 - usos de antagonistas do receptor de nk - Google Patents
usos de antagonistas do receptor de nkInfo
- Publication number
- BRPI1008008A2 BRPI1008008A2 BRPI1008008A BRPI1008008A BRPI1008008A2 BR PI1008008 A2 BRPI1008008 A2 BR PI1008008A2 BR PI1008008 A BRPI1008008 A BR PI1008008A BR PI1008008 A BRPI1008008 A BR PI1008008A BR PI1008008 A2 BRPI1008008 A2 BR PI1008008A2
- Authority
- BR
- Brazil
- Prior art keywords
- receptor antagonists
- antagonists
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15497309P | 2009-02-24 | 2009-02-24 | |
PCT/EP2010/052273 WO2010097381A1 (en) | 2009-02-24 | 2010-02-23 | Uses of nk receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1008008A2 true BRPI1008008A2 (pt) | 2016-02-23 |
Family
ID=42102184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1008008A BRPI1008008A2 (pt) | 2009-02-24 | 2010-02-23 | usos de antagonistas do receptor de nk |
Country Status (17)
Country | Link |
---|---|
US (1) | US20120077803A1 (pt) |
EP (1) | EP2400953A1 (pt) |
JP (1) | JP5425229B2 (pt) |
KR (1) | KR20110118830A (pt) |
CN (1) | CN102395358A (pt) |
AU (1) | AU2010217615C1 (pt) |
BR (1) | BRPI1008008A2 (pt) |
CA (1) | CA2753330A1 (pt) |
CL (1) | CL2011002045A1 (pt) |
EA (1) | EA201101207A1 (pt) |
IL (1) | IL214731A0 (pt) |
MA (1) | MA33059B1 (pt) |
MX (1) | MX2011008878A (pt) |
SG (1) | SG173758A1 (pt) |
TN (1) | TN2011000428A1 (pt) |
TW (1) | TW201034674A (pt) |
WO (1) | WO2010097381A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9603849B2 (en) * | 2012-10-11 | 2017-03-28 | Nerre Therapeutics Limited | Uses of orvepitant |
US20140179727A1 (en) | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
US8987289B2 (en) * | 2012-12-14 | 2015-03-24 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
CN109640981A (zh) * | 2016-06-29 | 2019-04-16 | 曼隆治疗公司 | 神经激肽-1拮抗剂用于治疗多种瘙痒病症的用途 |
SG11202100580UA (en) | 2018-07-23 | 2021-02-25 | Trevi Therapeutics Inc | Treatment of chronic cough, breathlessness and dyspnea |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2728166A1 (fr) * | 1994-12-19 | 1996-06-21 | Oreal | Composition topique contenant un antagoniste de substance p |
FR2740040B1 (fr) * | 1995-10-23 | 1997-12-05 | Oreal | Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p |
DE19541283A1 (de) * | 1995-11-06 | 1997-05-07 | Boehringer Ingelheim Kg | Neue Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
MY132550A (en) * | 1996-08-22 | 2007-10-31 | Novartis Ag | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists |
JP3793612B2 (ja) * | 1996-11-28 | 2006-07-05 | 花王株式会社 | 皮膚外用剤 |
CA2432543A1 (en) * | 2000-12-22 | 2002-07-04 | Takeda Chemical Industries, Ltd. | Combination drugs |
JP2003238986A (ja) * | 2002-02-22 | 2003-08-27 | Shiseido Co Ltd | サブスタンスp増加抑制剤 |
ITFI20030113A1 (it) * | 2003-04-24 | 2004-10-25 | Menarini Ricerche Spa | Composti lineari nk-2 antagonisti con caratteristiche basiche e formulazioni che li contengono. |
JO2630B1 (en) * | 2006-04-13 | 2012-06-17 | نوفارتيس ايه جي | Organic compounds |
CN101600724B (zh) * | 2006-10-16 | 2013-03-13 | 狮王株式会社 | Nk1受体拮抗剂组合物 |
EP1938804A1 (en) * | 2006-12-22 | 2008-07-02 | Novartis AG | Pharmaceutical formulation comprising neurokinin antagonist |
WO2009000038A1 (en) * | 2007-06-28 | 2008-12-31 | Cnsbio Pty Ltd | Combination methods and compositions for treatment of neuropathic pain |
-
2010
- 2010-02-23 BR BRPI1008008A patent/BRPI1008008A2/pt not_active IP Right Cessation
- 2010-02-23 SG SG2011059631A patent/SG173758A1/en unknown
- 2010-02-23 EA EA201101207A patent/EA201101207A1/ru unknown
- 2010-02-23 MX MX2011008878A patent/MX2011008878A/es not_active Application Discontinuation
- 2010-02-23 JP JP2011550600A patent/JP5425229B2/ja not_active Expired - Fee Related
- 2010-02-23 EP EP10705862A patent/EP2400953A1/en not_active Withdrawn
- 2010-02-23 TW TW099105199A patent/TW201034674A/zh unknown
- 2010-02-23 KR KR1020117022270A patent/KR20110118830A/ko not_active Application Discontinuation
- 2010-02-23 CA CA2753330A patent/CA2753330A1/en not_active Abandoned
- 2010-02-23 AU AU2010217615A patent/AU2010217615C1/en not_active Ceased
- 2010-02-23 MA MA34113A patent/MA33059B1/fr unknown
- 2010-02-23 US US13/202,741 patent/US20120077803A1/en not_active Abandoned
- 2010-02-23 WO PCT/EP2010/052273 patent/WO2010097381A1/en active Application Filing
- 2010-02-23 CN CN2010800166204A patent/CN102395358A/zh active Pending
-
2011
- 2011-08-18 IL IL214731A patent/IL214731A0/en unknown
- 2011-08-19 TN TN2011000428A patent/TN2011000428A1/fr unknown
- 2011-08-23 CL CL2011002045A patent/CL2011002045A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2011002045A1 (es) | 2012-01-13 |
TN2011000428A1 (en) | 2013-03-27 |
AU2010217615C1 (en) | 2013-05-23 |
SG173758A1 (en) | 2011-09-29 |
AU2010217615A1 (en) | 2011-09-08 |
EA201101207A1 (ru) | 2012-04-30 |
JP2012518622A (ja) | 2012-08-16 |
EP2400953A1 (en) | 2012-01-04 |
US20120077803A1 (en) | 2012-03-29 |
KR20110118830A (ko) | 2011-11-01 |
CA2753330A1 (en) | 2010-09-02 |
JP5425229B2 (ja) | 2014-02-26 |
MX2011008878A (es) | 2011-09-21 |
MA33059B1 (fr) | 2012-02-01 |
CN102395358A (zh) | 2012-03-28 |
WO2010097381A1 (en) | 2010-09-02 |
TW201034674A (en) | 2010-10-01 |
IL214731A0 (en) | 2011-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR22C1044I1 (fr) | Antagonistes du recepteur cgrp | |
CY2023022I1 (el) | Ανταγωνιστες υποδοχεων cgrp αζαϊνδανιου καρβοξαμιδιου πιπεριδινονης | |
BR112012015873A2 (pt) | antagonistas de receptores ccr2 e usos dos mesmos | |
BRPI0919844A2 (pt) | compostos de azaindazol como antagonistas do receptor ccr1 | |
PL2927224T3 (pl) | Antagoniści receptora | |
BRPI0910118A2 (pt) | antagonistas de receptores do glucagon | |
EP2411001A4 (en) | P2X3 RECEPTOR ANTAGONISTS FOR PAIN TREATMENT | |
BR112014001030A2 (pt) | anticorpos anti-receptor alfa de folato e usos destes | |
BRPI0913930A2 (pt) | antagonistas de receptores de prostaglandinas d2 | |
BR112012003263A2 (pt) | formulações intravenosas de antagonistas de neuroquinina-1 | |
EP2410857A4 (en) | ANTAGONISTS OF THE P2X3 RECEPTOR FOR THE TREATMENT OF PAIN | |
DK2443104T3 (da) | Disubstituerede phthalazin-hedgehog-sti-antagonister | |
DK2501703T3 (da) | Spiropiperidinforbindelser som orl-1-receptorantagonister | |
SMT201600078B (it) | Antagonista del recettore per cgrp | |
BRPI0717937A2 (pt) | Compostos de pirazona como antagonistas do receptor mineralocorticóide | |
EP2427430A4 (en) | 5-OXO-ETE RECEPTOR ANTAGONIST COMPOUNDS | |
EP2410858A4 (en) | P2X3 RECEPTOR ANTAGONISTS FOR PAIN TREATMENT | |
DK2252581T3 (da) | Kappa-selektiv opioidreceptorantagonist | |
BRPI1008008A2 (pt) | usos de antagonistas do receptor de nk | |
BR112012003976A2 (pt) | antagonistas de receptor glyt1 carbocíclico | |
BRPI0720078A2 (pt) | 2-aminoquinolinas como antagonistas de receptores de 5-ht(5a) | |
BRPI0915834A2 (pt) | 6-(1-piperazinil)-piridazinas substituídas como antagonistas do receptor de 5-ht6 | |
BRPI1013617A2 (pt) | derivados de piperidina como antagonistas de receptor de nk3 | |
EP2451281A4 (en) | ANTAGONISTS OF OREXIN RECEPTORS BASED ON TETRAHYDRONAPHTHYRIDINE | |
BRPI1014668A2 (pt) | antagonistas ccr3 de arilsulfonamida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2370 DE 07-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |